De novo design of modular and tunable allosteric biosensors

Naturally occurring allosteric protein switches have been repurposed for developing novel biosensors and reporters for cellular and clinical applications 1, but the number of such switches is limited, and engineering them is often challenging as each is different. Here, we show that a very general class of allosteric protein-based biosensors can be created by inverting the flow of information through de novo designed protein switches in which binding of a peptide key triggers biological outputs of interest 2. Using broadly applicable design principles, we allosterically couple binding of protein analytes of interest to the reconstitution of luciferase activity and a bioluminescent readout through the association of designed lock and key proteins. Because the sensor is based purely on thermodynamic coupling of analyte binding to switch activation, only one target binding domain is required, which simplifies sensor design and allows direct readout in solution. We demonstrate the modularity of this platform by creating biosensors that, with little optimization, sensitively detect the anti-apoptosis protein Bcl-2, the hIgG1 Fc domain, the Her2 receptor, and Botulinum neurotoxin B, as well as biosensors for cardiac Troponin I and an anti-Hepatitis B virus (HBV) antibody that achieve the sub-nanomolar sensitivity necessary to detect clinically relevant concentrations of these molecules. Given the current need for diagnostic tools for tracking COVID-19 3, we use the approach to design sensors of antibodies against SARS-CoV-2 protein epitopes and of the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein. The latter, which incorporates a de novo designed RBD binder, has a limit of detection of 15pM with an up to seventeen fold increase in luminescence upon addition of RBD. The modularity and sensitivity of the platform should enable the rapid construction of sensors for a wide range of analytes and highlights the power of de novo protein design to create multi-state protein systems with new and useful functions.

[1]  D. Baker,et al.  RosettaRemodel: A Generalized Framework for Flexible Backbone Protein Design , 2011, PloS one.

[2]  Michael J. McPherson,et al.  Affimer-enzyme-inhibitor switch sensor for rapid wash-free assays of multimeric proteins. , 2019, ACS sensors.

[3]  Peter H. Seeberger,et al.  Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series , 2020, medRxiv.

[4]  Hyo Jeong Hong,et al.  Enhanced humanization and affinity maturation of neutralizing anti‐hepatitis B virus preS1 antibody based on antigen–antibody complex structure , 2015, FEBS letters.

[5]  Alberto Schena,et al.  Modulating protein activity using tethered ligands with mutually exclusive binding sites , 2015, Nature Communications.

[6]  Luc Patiny,et al.  A biosensor for measuring NAD+ levels at the point of care , 2019, Nature Metabolism.

[7]  Michael J MacCoss,et al.  Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer , 2016, eLife.

[8]  Vincent Wai-Sun Wong,et al.  The role of quantitative hepatitis B surface antigen revisited. , 2017, Journal of hepatology.

[9]  Maarten Merkx,et al.  Detection of Antibodies in Blood Plasma Using Bioluminescent Sensor Proteins and a Smartphone. , 2016, Analytical chemistry.

[10]  L. Abrahmsén,et al.  Structural basis for high-affinity HER2 receptor binding by an engineered protein , 2010, Proceedings of the National Academy of Sciences.

[11]  Christopher J. Williams,et al.  Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix , 2019, Acta crystallographica. Section D, Structural biology.

[12]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[13]  C. Gwenin,et al.  Rapid Detection of Botulinum Neurotoxins—A Review , 2019, Toxins.

[14]  Hui-wang Ai,et al.  Development and Applications of Bioluminescent and Chemiluminescent Reporters and Biosensors. , 2019, Annual review of analytical chemistry.

[15]  Vikram Khipple Mulligan,et al.  De Novo Design of Bioactive Protein Switches , 2019, Nature.

[16]  Robério Amorim de Almeida Pondé,et al.  Expression and detection of anti-HBs antibodies after hepatitis B virus infection or vaccination in the context of protective immunity , 2019, Archives of Virology.

[17]  Keisuke Tenda,et al.  Paper‐Based Antibody Detection Devices Using Bioluminescent BRET‐Switching Sensor Proteins , 2018, Angewandte Chemie.

[18]  Lu Zhang,et al.  Massively parallel de novo protein design for targeted therapeutics , 2017, Nature.

[19]  K. Christopher Garcia,et al.  Mechanistic and structural insights into the proteolytic activation of Vibrio cholera MARTX toxin , 2009, Nature chemical biology.

[20]  Maarten Merkx,et al.  Dual-Color Bioluminescent Sensor Proteins for Therapeutic Drug Monitoring of Antitumor Antibodies , 2018, Analytical chemistry.

[21]  P. S. Kim,et al.  Context-dependent secondary structure formation of a designed protein sequence , 1996, Nature.

[22]  Pierre-Alain Binz,et al.  Semisynthetic sensor proteins enable metabolic assays at the point of care , 2018, Science.

[23]  S. Locarnini,et al.  Hepatitis B surface antigen quantification: Not what it seems on the surface , 2012, Hepatology.

[24]  Christian Schindler,et al.  One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. , 2015, The American journal of medicine.

[25]  Malik Peiris,et al.  Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[26]  Joseph Gligorov,et al.  The extracellular domain of Her2 in serum as a biomarker of breast cancer , 2018, Laboratory Investigation.

[27]  Kai Johnsson,et al.  A General Strategy for the Semisynthesis of Ratiometric Fluorescent Sensor Proteins with Increased Dynamic Range. , 2016, Journal of the American Chemical Society.

[28]  Marc Ostermeier,et al.  Construction of Protein Switches by Domain Insertion and Directed Evolution. , 2017, Methods in molecular biology.

[29]  Anastassis Perrakis,et al.  Developments in the CCP4 molecular-graphics project. , 2004, Acta crystallographica. Section D, Biological crystallography.

[30]  Alberto Schena,et al.  Corrigendum: Modulating protein activity using tethered ligands with mutually exclusive binding sites , 2016, Nature communications.

[31]  Xiaobo Yu,et al.  SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution , 2020, bioRxiv.

[32]  Viktor Stein,et al.  Synthetic protein switches: design principles and applications. , 2015, Trends in biotechnology.

[33]  Pei Zhou,et al.  Suppression of conformational heterogeneity at a protein–protein interface , 2015, Proceedings of the National Academy of Sciences.

[34]  Shibo Jiang,et al.  Identification of Immunodominant Epitopes on the Membrane Protein of the Severe Acute Respiratory Syndrome-Associated Coronavirus , 2005, Journal of Clinical Microbiology.

[35]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[36]  P. Chan,et al.  Specific epitopes of the structural and hypothetical proteins elicit variable humoral responses in SARS patients , 2006, Journal of Clinical Pathology.

[37]  Meric A. Ovacik,et al.  Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development , 2018, Clinical and translational science.

[38]  Axel T. Brunger,et al.  Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity , 2006, Nature.

[39]  C. Vickers,et al.  Generalizable Protein Biosensors Based on Synthetic Switch Modules. , 2019, Journal of the American Chemical Society.

[40]  Brock F. Binkowski,et al.  NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells. , 2016, ACS chemical biology.

[41]  Eric C Greenwald,et al.  Genetically Encoded Fluorescent Biosensors Illuminate the Spatiotemporal Regulation of Signaling Networks. , 2018, Chemical reviews.

[42]  Maarten Merkx,et al.  Semisynthetic Bioluminescent Sensor Proteins for Direct Detection of Antibodies and Small Molecules in Solution , 2017, ACS sensors.

[43]  S. Ryu,et al.  Broadly neutralizing anti-hepatitis B virus antibody reveals a complementarity determining region H3 lid-opening mechanism , 2007, Proceedings of the National Academy of Sciences.

[44]  Andrew Pollard,et al.  Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel , 2020, Wellcome open research.

[45]  Claudia E. Vickers,et al.  Caged activators of artificial allosteric protein biosensors. , 2020, ACS synthetic biology.

[46]  M. Collins,et al.  Serologic Tools and Strategies to Support Intervention Trials to Combat Zika Virus Infection and Disease , 2019, Tropical medicine and infectious disease.